Tuesday Dossier Submission Window for NMRA Medical Device Applications in Sri Lanka

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The acceptance window for Sri Lankan device registration dossiers is every Tuesday from 9:00 to 15:00, and the dossier must be delivered in person to the Dossier Accepting Point on the second floor of the NMRA; no other time is accepted. Before attending in person, the applicant must first complete the online application form, available through the Google Form link on the official website or the QR code published there. An incomplete submission is not accepted. The combination of a single weekly window, a physical delivery requirement and a strict completeness check means that filing logistics carry real regulatory weight in Sri Lanka, and a missed or rejected Tuesday costs a full week.

  • Acceptance time: every Tuesday, 9:00 a.m. to 3:00 p.m., per the NMRA medical device page.
  • Acceptance location: the Dossier Accepting Point, 2nd Floor, NMRA.
  • Prerequisite: the online application form must be completed before the physical submission (Google Form or the QR code on the official website).
  • Completeness: incomplete submissions are not accepted.
  • Dossier binding: box files sealed on the side with green tape; the cover states the generic name, brand name, manufacturer name and address, the local agent and the dossier type, per GL-034.
  • Page numbering and index: all pages numbered; an index with titles and page numbers pasted inside the documents.
  • Responsible person: the dossier must contain the information of the person responsible for regulatory affairs.
  • Multiple agents: where the legal manufacturer appoints several local agents, a formalised power of attorney listing all local agents, the product scope and the production sites must be submitted.

2. Legal basis

The Tuesday window, the physical delivery requirement and the completeness rule come from the NMRA medical device page, while the binding and formatting requirements come from GL-034. The table below places the two layers side by side, first the procedural rules of the window itself and then the physical presentation rules that the accepting officer applies on the spot.

It is worth noting that the multiple-agent rule is the only row that reaches into the corporate structure behind the product. Where several local agents are appointed, the power of attorney must be formalised and must list every agent together with the product scope and the production sites, so this document should be drafted early rather than assembled on submission day.

MatterContentSource
Acceptance timeEvery Tuesday, 9:00 a.m. to 3:00 p.m.NMRA medical device page
Acceptance locationDossier Accepting Point, 2nd Floor, NMRASame source
Prerequisite actionThe online application form must be completed before the physical submission (Google Form or official website QR code)Same source
Completeness requirementIncomplete submissions are not acceptedSame source
Dossier bindingBox files sealed on the side with green tape; the cover states the generic name, brand name, manufacturer name and address, the local agent and the dossier typeGL-034
Page numbers and indexAll pages numbered; an index with titles and page numbers pasted inside the documentsSame source
Responsible person informationThe dossier must include the information of the person responsible for regulatory affairsSame source
Multiple-agent situationsWhere the legal manufacturer appoints several local agents, a formalised power of attorney must be submitted listing all local agents, the product scope and the production sitesSame source

3. Expert insights

Insight one: this is a once-a-week, scarce window, and missing it means losing a week. Unlike the mandatory online portals of some neighbouring markets, Sri Lanka keeps a physical submission with an extremely narrow window. Project schedules must therefore anchor on the Tuesday and work the document completion date backwards from it. A team that plans backwards from a fixed Tuesday knows exactly when drafting, translation, printing and internal sign-off must each finish, and any slip becomes visible days before it costs a week.

Insight two: the online form and the paper dossier run in series, not as alternatives. Filling in the online form without attending in person equals not filing at all; attending without the online form is equally unacceptable. Both actions are indispensable, and neither can substitute for the other. The practical consequence is that the online form should be completed and confirmed before the travelling team leaves the office, so the two actions land in the correct order on the same Tuesday.

Insight three: the binding requirements look trivial but are acceptance preconditions. Green tape, cover elements, page numbering, the index and the responsible person information are all items the accepting officer checks on the spot, and any single non-conforming item can mean the dossier is turned away on the spot. What looks like stationery is in fact the first substantive gate the file passes, and treating it with that seriousness removes an entire class of avoidable rejections.

4. Practical recommendations

  • Apply a T-3 document freeze rule: with the target Tuesday as day T, freeze all document versions three working days before T, and afterwards perform only formatting and binding checks, with no further content changes.
  • Prepare a day-of-submission contingency kit (spare printouts, binding materials, originals of the powers of attorney), so that any item flagged on the spot can be corrected immediately without waiting another week.
  • Complete the online application form before departure and carry confirmation of it to the acceptance point.
  • Assemble the dossier strictly to the binding specification: green-taped box file, full cover elements, page numbers, internal index and responsible person information.
  • Rehearse the completeness self-check against the official checklist before the Tuesday, not at the counter.

5. Verification checklist

  • □ The target Tuesday has been fixed as the submission day
  • □ Document versions have been frozen under the T-3 rule
  • □ The online application form has been completed
  • □ The dossier has been prepared to the binding requirements (green tape, cover elements, page numbers, index, responsible person)
  • □ The day-of-submission contingency kit is ready
  • □ The submission location has been confirmed as the Dossier Accepting Point on the 2nd Floor of the NMRA
  • □ The completeness self-check has been completed against the official checklist
  • □ Confirmation of the completed online form has been carried to the acceptance point by the attending team

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of 28 October 2026.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail